1 recruiting. 1 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Recruiting 1 |
| Phase 2 | 1 | Recruiting 1 |
Follow Chaser Therapeutics, Inc.: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| PBSS1113 in Combination With Azacitidine to Treat Patients With AML/MDS PBSS1113 - Acute Myeloid Leukemia (AML), MDS (Myelodysplastic Syndrome) | Phase 1 / Phase 2 | Recruiting | Chaser Therapeutics, Inc. | 29 | 2025-09-08 | 2026-08-14 |
Anemia, Refractory, with Excess of Blasts (1) · Leukemia, Myeloid, Acute (1)
China (1)